Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yousef R Badran

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Expert Review of Anticancer Therapy|July 30, 2020
Immune-related adverse events: what we've learned and where we're headingYousef R Badran, Donna E Leet, Michael Dougan
Current Gastroenterology Reports|October 20, 2022
Update on Immune Checkpoint Inhibitor EnterocolitisMolly R Kelly-Goss, Yousef R Badran, Michael Dougan
Journal of Thrombosis and Thrombolysis|July 13, 2022
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacementZain M Virk, Andrew B Song, Yousef R Badran, et al.
The New England Journal of Medicine|October 14, 2022
Case 31-2022: A 72-Year-Old Man with Heartburn, Nausea, and Inability to EatKyle D Staller, Yousef R Badran, David A Rosman, et al.
The Journal of Allergy and Clinical Immunology|August 23, 2017
Advances in basic and clinical immunology in 2016Javier Chinen, Yousef R Badran, Raif S Geha, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 20, 2015
Effect of Interleukins on Antibody Production by Epstein-Barr Virus Transformed B CellsAisheh I Ali, Yousef R Badran, Mona R Hassuneh, et al.
Journal for Immunotherapy of Cancer|August 24, 2019
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse eventsYousef R Badran, Justine V Cohen, Priscilla K Brastianos, et al.
Clinical Immunology (Orlando, Fla.)|August 20, 2016
Mutations in pyrin masquerading as a primary immunodeficiencyYousef R Badran, Mariam Rajab, Rima Hanna-Wakim, et al.
Clinical Immunology (Orlando, Fla.)|April 12, 2016
Combined immunodeficiency due to a homozygous mutation in ORAI1 that deletes the C-terminus that interacts with STIM 1Yousef R Badran, Michel J Massaad, Wayne Bainter, et al.
The Journal of Experimental Medicine|June 11, 2017
Human <i>RELA</i> haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulcerationYousef R Badran, Fatma Dedeoglu, Juan Manuel Leyva Castillo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Expert Review of Anticancer Therapy|July 30, 2020
Immune-related adverse events: what we've learned and where we're headingYousef R Badran, Donna E Leet, Michael Dougan
Current Gastroenterology Reports|October 20, 2022
Update on Immune Checkpoint Inhibitor EnterocolitisMolly R Kelly-Goss, Yousef R Badran, Michael Dougan
Journal of Thrombosis and Thrombolysis|July 13, 2022
Systemic bevacizumab as salvage therapy for persistent severe bleeding and anemia in heyde syndrome following aortic valve replacementZain M Virk, Andrew B Song, Yousef R Badran, et al.
The New England Journal of Medicine|October 14, 2022
Case 31-2022: A 72-Year-Old Man with Heartburn, Nausea, and Inability to EatKyle D Staller, Yousef R Badran, David A Rosman, et al.
The Journal of Allergy and Clinical Immunology|August 23, 2017
Advances in basic and clinical immunology in 2016Javier Chinen, Yousef R Badran, Raif S Geha, et al.
Monoclonal Antibodies in Immunodiagnosis and Immunotherapy|June 20, 2015
Effect of Interleukins on Antibody Production by Epstein-Barr Virus Transformed B CellsAisheh I Ali, Yousef R Badran, Mona R Hassuneh, et al.
Journal for Immunotherapy of Cancer|August 24, 2019
Concurrent therapy with immune checkpoint inhibitors and TNFα blockade in patients with gastrointestinal immune-related adverse eventsYousef R Badran, Justine V Cohen, Priscilla K Brastianos, et al.
Clinical Immunology (Orlando, Fla.)|August 20, 2016
Mutations in pyrin masquerading as a primary immunodeficiencyYousef R Badran, Mariam Rajab, Rima Hanna-Wakim, et al.
Clinical Immunology (Orlando, Fla.)|April 12, 2016
Combined immunodeficiency due to a homozygous mutation in ORAI1 that deletes the C-terminus that interacts with STIM 1Yousef R Badran, Michel J Massaad, Wayne Bainter, et al.
The Journal of Experimental Medicine|June 11, 2017
Human <i>RELA</i> haploinsufficiency results in autosomal-dominant chronic mucocutaneous ulcerationYousef R Badran, Fatma Dedeoglu, Juan Manuel Leyva Castillo, et al.
Pageof 2